ENTYVIOCONNECT HOME Trademark

Trademark Overview


On Monday, October 1, 2018, a trademark application was filed for ENTYVIOCONNECT HOME with the United States Patent and Trademark Office. The USPTO has given the ENTYVIOCONNECT HOME trademark a serial number of 88138617. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, November 23, 2020. This trademark is owned by Millennium Pharmaceuticals, Inc.. The ENTYVIOCONNECT HOME trademark is filed in the Advertising, Business and Retail Services and Medical & Beauty Services & Agricultural Services categories with the following description:

Patient relationship management services, namely, direct contact between medical patients and medical practitioners to coordinate and schedule infusion treatments

Health care services, namely, providing one-on-one information about treatment, support, counseling, and training to ulcerative colitis and Crohn's disease patients; health care and disease management services provided to patients, namely, monitoring and management of patients undergoing infusion treatments, including monitoring of infusion treatment, patient prescriptions and health data; multi-disciplinary, integrative, outpatient health care delivery and medical consultations; Health care services, namely, home infusion of pharmaceuticals for the treatment of ulcerative colitis and Crohn's Disease
entyvioconnect home

General Information


Serial Number88138617
Word MarkENTYVIOCONNECT HOME
Filing DateMonday, October 1, 2018
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, November 23, 2020
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, August 27, 2019

Trademark Statements


Disclaimer with Predetermined Text"HOME"
Goods and ServicesPatient relationship management services, namely, direct contact between medical patients and medical practitioners to coordinate and schedule infusion treatments
Goods and ServicesHealth care services, namely, providing one-on-one information about treatment, support, counseling, and training to ulcerative colitis and Crohn's disease patients; health care and disease management services provided to patients, namely, monitoring and management of patients undergoing infusion treatments, including monitoring of infusion treatment, patient prescriptions and health data; multi-disciplinary, integrative, outpatient health care delivery and medical consultations; Health care services, namely, home infusion of pharmaceuticals for the treatment of ulcerative colitis and Crohn's Disease
Pseudo MarkENTYVIO CONNECT HOME

Classification Information


International Class035 - Advertising; business management; business administration; office functions.
US Class Codes100, 101, 102
Class Status Code6 - Active
Class Status DateTuesday, October 9, 2018
Primary Code035
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class044 - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateTuesday, October 9, 2018
Primary Code044
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameMillennium Pharmaceuticals, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressCambridge, MA 02139

Party NameMillennium Pharmaceuticals, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressCambridge, MA 02139

Trademark Events


Event DateEvent Description
Monday, November 23, 2020ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Monday, November 23, 2020ABANDONMENT - NO USE STATEMENT FILED
Wednesday, July 1, 2020APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Wednesday, July 1, 2020TEAS CHANGE OF CORRESPONDENCE RECEIVED
Wednesday, July 1, 2020ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Wednesday, July 1, 2020TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Wednesday, July 1, 2020TEAS CHANGE OF OWNER ADDRESS RECEIVED
Friday, April 10, 2020NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, April 8, 2020EXTENSION 1 GRANTED
Wednesday, April 8, 2020EXTENSION 1 FILED
Wednesday, April 8, 2020TEAS EXTENSION RECEIVED
Tuesday, October 22, 2019NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Monday, September 23, 2019ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Monday, September 23, 2019TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Thursday, August 29, 2019TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, August 27, 2019OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, August 27, 2019PUBLISHED FOR OPPOSITION
Wednesday, August 7, 2019NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Sunday, July 21, 2019ASSIGNED TO LIE
Wednesday, July 10, 2019APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, July 10, 2019TEAS/EMAIL CORRESPONDENCE ENTERED
Tuesday, July 9, 2019CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, July 9, 2019TEAS RESPONSE TO OFFICE ACTION RECEIVED
Monday, January 14, 2019NOTIFICATION OF NON-FINAL ACTION E-MAILED
Monday, January 14, 2019NON-FINAL ACTION E-MAILED
Monday, January 14, 2019NON-FINAL ACTION WRITTEN
Friday, January 11, 2019ASSIGNED TO EXAMINER
Tuesday, October 9, 2018NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Thursday, October 4, 2018NEW APPLICATION ENTERED IN TRAM